Bicocca Open Archive

Logo unimib boa
FAGIUOLI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.160
AS - Asia 20.830
EU - Europa 13.878
SA - Sud America 2.976
Continente sconosciuto - Info sul continente non disponibili 1.676
AF - Africa 473
OC - Oceania 34
Totale 68.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.097
SG - Singapore 6.977
IT - Italia 3.916
HK - Hong Kong 3.896
VN - Vietnam 3.863
RU - Federazione Russa 3.018
CA - Canada 2.737
CN - Cina 2.656
BR - Brasile 2.187
IE - Irlanda 1.776
DE - Germania 1.468
SE - Svezia 1.255
BD - Bangladesh 881
IN - India 682
FR - Francia 604
GB - Regno Unito 484
AR - Argentina 276
KR - Corea 257
UA - Ucraina 256
IQ - Iraq 236
FI - Finlandia 229
ID - Indonesia 217
TR - Turchia 185
NL - Olanda 180
ZA - Sudafrica 149
PK - Pakistan 147
AT - Austria 128
MX - Messico 127
CO - Colombia 122
ES - Italia 119
JP - Giappone 117
SA - Arabia Saudita 112
PH - Filippine 111
EC - Ecuador 108
PL - Polonia 98
VE - Venezuela 98
MY - Malesia 80
UZ - Uzbekistan 58
DK - Danimarca 55
EG - Egitto 53
CL - Cile 50
PY - Paraguay 49
JM - Giamaica 48
BE - Belgio 46
KE - Kenya 46
MA - Marocco 43
CR - Costa Rica 39
JO - Giordania 38
NP - Nepal 37
PE - Perù 37
TN - Tunisia 37
AE - Emirati Arabi Uniti 33
DZ - Algeria 33
CZ - Repubblica Ceca 32
ET - Etiopia 30
CH - Svizzera 28
AU - Australia 26
AZ - Azerbaigian 26
RO - Romania 24
AL - Albania 22
BO - Bolivia 22
LT - Lituania 22
PT - Portogallo 22
TH - Thailandia 22
IL - Israele 21
LB - Libano 21
TW - Taiwan 20
UY - Uruguay 20
PS - Palestinian Territory 19
SN - Senegal 18
HN - Honduras 17
OM - Oman 17
IR - Iran 15
PA - Panama 15
TT - Trinidad e Tobago 15
BG - Bulgaria 13
AO - Angola 12
DO - Repubblica Dominicana 12
EU - Europa 12
KG - Kirghizistan 12
LY - Libia 12
GR - Grecia 10
GT - Guatemala 10
KZ - Kazakistan 10
NI - Nicaragua 10
EE - Estonia 9
RS - Serbia 9
SV - El Salvador 9
BH - Bahrain 8
NO - Norvegia 8
SK - Slovacchia (Repubblica Slovacca) 8
BY - Bielorussia 7
GA - Gabon 7
HU - Ungheria 7
KW - Kuwait 7
MN - Mongolia 7
CI - Costa d'Avorio 6
MD - Moldavia 6
MM - Myanmar 6
NG - Nigeria 6
Totale 66.248
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.833
Singapore 3.721
Ashburn 2.550
Toronto 2.425
San Jose 2.134
Dublin 1.722
Ann Arbor 1.271
Ho Chi Minh City 1.219
Milan 1.066
New York 1.066
Frankfurt am Main 1.035
Hanoi 1.004
Princeton 894
Santa Clara 783
Council Bluffs 742
Chicago 709
Fairfield 672
Chandler 662
Dallas 662
The Dalles 653
Los Angeles 628
Houston 486
Woodbridge 468
Lauterbourg 422
Rome 395
Moscow 363
Beijing 342
Lawrence 329
Wilmington 324
Altamura 321
Seattle 286
Buffalo 285
Hefei 285
Cambridge 251
Seoul 240
São Paulo 208
Shanghai 187
Jacksonville 184
San Diego 171
Pune 163
Columbus 145
Dearborn 144
Helsinki 137
Da Nang 136
Jakarta 133
Haiphong 124
London 116
Boardman 108
Phoenix 108
Orem 105
Baghdad 101
Salt Lake City 92
Tokyo 92
Atlanta 91
Figino 91
Andover 89
Brooklyn 86
Nuremberg 85
Rio de Janeiro 85
Washington 83
Montreal 75
Hải Dương 74
Warsaw 74
Boston 73
Naples 72
Guangzhou 71
Johannesburg 71
Quận Bình Thạnh 69
Turin 69
Chennai 67
Vienna 66
Munich 65
Nanjing 62
Denver 61
Dhaka 59
Thái Nguyên 57
Biên Hòa 54
San Francisco 54
Ha Long 50
Hangzhou 50
Kuala Lumpur 50
Philadelphia 49
Tashkent 47
Vũng Tàu 47
Brasília 45
Florence 44
Mumbai 44
Ninh Bình 44
Stockholm 44
Lahore 43
Tampa 42
Amsterdam 41
Miami 41
Can Tho 40
Fremont 40
Belo Horizonte 39
Istanbul 39
Bergamo 38
Bologna 38
Quito 38
Totale 39.458
Salva come PNG Salva come JPEG
Nome #
Long-term outcomes of Yttrium-90 transarterial radioembolization for patients with hepatocellular carcinoma 1.352
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group 546
Estimation of lifetime costs for patients receiving a transplant: the case of liver transplantation related to hepatitis B in Italy 507
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 482
Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients 478
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 405
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 400
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 377
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 372
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 362
Health related quality of life in chronic liver diseases 355
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 350
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 344
Health Related Quality of Life in the Major Liver Conditions 336
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 335
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 329
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 326
The impact of liver disease on the health-related quality of life 326
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 324
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 320
High rates of 30-day mortality in patients with cirrhosis and COVID-19 320
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 317
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 315
Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysis 315
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 308
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 306
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients 305
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 305
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 305
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 301
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 300
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 294
Correction: Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group (Hepatology International, (2024), 18, 5, (1416-1430), 10.1007/s12072-024-10703-4) 293
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 292
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 287
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 280
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 277
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 277
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 275
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 274
Percutaneous management of chronic total occlusion of the portal vein: a retrospective analysis of technical aspects and outcomes 272
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 272
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 271
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) 271
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 267
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 260
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 259
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 258
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 257
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 254
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 252
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 252
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 249
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 248
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study 248
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 248
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study 246
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 245
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 244
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue 243
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 243
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence 242
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma 240
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 238
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 235
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 234
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT) 234
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study 230
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting 230
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 229
Antibiotic Stewardship Based on Colonization with Multi-Drug-Resistant Bacteria in Liver Transplantation: A Narrative Review 227
Non-anatomical revascularization of the portal vein in children with non-cirrhotic extrahepatic portal vein obstruction 223
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation 222
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 222
COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study 221
One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity 220
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 220
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 218
Bergamo and Covid-19: How the Dark Can Turn to Light 218
Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre Study 216
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 215
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 213
Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome 212
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 211
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients 211
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 209
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 202
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study 202
Bulevirtide improves liver function in candidates for liver transplant with advanced HDV cirrhosis and severe portal hypertension 199
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 196
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 (Leukemia, (2021), 35, 9, (2710-2714), 10.1038/s41375-021-01299-x) 196
Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19 196
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 196
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference 196
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 195
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 195
The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): A post-hoc between-sex analysis 194
HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation 193
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 191
Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis 188
Totale 28.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 275.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 275.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.292 0 0 0 213 68 155 43 1.395 86 314 245 773
2022/20235.072 798 1.485 460 295 306 871 64 292 218 61 150 72
2023/20245.053 74 128 152 226 754 1.452 973 162 461 73 64 534
2024/202514.328 822 1.742 601 606 1.226 389 614 462 2.010 1.826 966 3.064
2025/202629.097 2.866 1.925 1.987 2.256 2.707 1.476 3.916 1.460 2.382 2.405 3.361 2.356
2026/20276.327 957 1.543 3.385 442 0 0 0 0 0 0 0 0
Totale 68.027